| Non-Hodgkin Lymphoma (NHL) |
1 |
1 |
| Radiation Therapy |
0 |
0.99 |
| Lymphoma |
0 |
0.98 |
| B-Cell Lymphoma |
0 |
0.36 |
| Patient Safety |
0 |
0.35 |
| Cataract |
0 |
0.26 |
| Orbit |
0 |
0.21 |
| Toxicology |
0 |
0.2 |
| Surgery |
0 |
0.17 |
| Mucosa-Associated Lymphoid Tissue |
0 |
0.12 |
| Adverse Effects |
0 |
0.09 |
| Clinical Guidelines |
0 |
0.09 |
| Hospital |
0 |
0.09 |
| Tissue |
0 |
0.09 |
| Dermatitis |
0 |
0.08 |
| Dry Eye |
0 |
0.08 |
| Healthcare and Medical Technology |
0 |
0.08 |
| Postoperative Complications |
0 |
0.06 |